Publications
- Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis2021 | First Faculty of Medicine
- Validating atlas-based lesion disconnectomics in multiple sclerosis: A retrospective multi-centric study2021 | First Faculty of Medicine
- Pathological cut-offs of global and regional brain volume loss in multiple sclerosis2019 | First Faculty of Medicine
- Brain volumetric correlates of dysarthria in multiple sclerosis2019 | First Faculty of Medicine
- Characteristics of motor speech phenotypes in multiple sclerosis2018 | First Faculty of Medicine
- Serum lipid profile changes predict neurodegeneration in interferon-beta 1a-treated multiple sclerosis patients2017 | First Faculty of Medicine
- Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients2017 | First Faculty of Medicine
- Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later2016 | First Faculty of Medicine
- Early magnetic resonance imaging predictors of clinical progression after 48months in clinically isolated syndrome patients treated with intramuscular interferon beta-1a2015 | First Faculty of Medicine
- Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome2015 | First Faculty of Medicine
Loading network view...
